RESUMEN
BACKGROUND: Topical photodynamic therapy (PDT) is an approved treatment for actinic keratosis (AK). To enhance the efficacy of PDT for AKs, physical and chemical pretreatments have been suggested. OBJECTIVES: To compare the efficacy and safety of the combination of topical calcipotriol (CAL) before methyl aminolaevulinate (MAL)-PDT for AKs of the scalp vs. conventional MAL-PDT in a randomized controlled clinical trial. METHODS: Twenty patients with multiple AKs on the scalp were randomized to receive conventional MAL-PDT with previous curettage on one side of the scalp and CAL-assisted MAL-PDT once a day for 15 days before illumination on the other side. After 3 months, patients were evaluated for clearance of AKs, side-effects and histopathology before and after the procedure. Protoporphyrin IX (PpIX) fluorescence was measured before and after illumination on both sides. RESULTS: All 20 patients completed the study. Overall AK clearance rates were 92·1% and 82·0% for CAL-PDT and conventional PDT, respectively (P < 0·001). Grade 1 AKs showed similar response rates for both sides (P = 0·055). However, grade II AKs showed more improvement on the CAL-PDT side (90%) than on the MAL-PDT side (63%) (P < 0·001). Before illumination, PpIX fluorescence intensity was higher on the CAL-assisted side (P = 0·048). The treatment was more painful on the CAL-PDT side, although well tolerated. The mean visual analogue scale score was 5·4 ± 1·4 on the CAL-PDT side and 4·0 ± 0·69 on the conventional MAL-PDT side (P = 0·001). Side-effects such as erythema (P = 0·019), oedema (P = 0·002) and crusts (P < 0·001) were more pronounced on the CAL-assisted side. Histopathological analyses were obtained from five patients and both sides showed improved keratinocyte atypia following PDT, with slightly more improvement on the CAL-assisted side. CONCLUSIONS: CAL-assisted PDT proved to be safe and more effective than conventional MAL-PDT for the treatment of AKs on the scalp. CAL pretreatment increased PpIX accumulation within the skin and may have enhanced the efficacy in this first human trial.
Asunto(s)
Fármacos Dermatológicos/administración & dosificación , Queratosis Actínica/tratamiento farmacológico , Dolor/diagnóstico , Fotoquimioterapia/métodos , Fármacos Fotosensibilizantes/administración & dosificación , Dermatosis del Cuero Cabelludo/tratamiento farmacológico , Anciano , Anciano de 80 o más Años , Ácido Aminolevulínico/administración & dosificación , Ácido Aminolevulínico/efectos adversos , Ácido Aminolevulínico/análogos & derivados , Calcitriol/administración & dosificación , Calcitriol/efectos adversos , Calcitriol/análogos & derivados , Fármacos Dermatológicos/efectos adversos , Quimioterapia Combinada/efectos adversos , Quimioterapia Combinada/métodos , Estudios de Seguimiento , Humanos , Queratosis Actínica/patología , Masculino , Persona de Mediana Edad , Dolor/inducido químicamente , Dimensión del Dolor , Fotoquimioterapia/efectos adversos , Fármacos Fotosensibilizantes/efectos adversos , Dermatosis del Cuero Cabelludo/patología , Piel/efectos de los fármacos , Piel/patología , Resultado del TratamientoRESUMEN
Thirteen patients with epidermodysplasia verruciformis (EV) were studied over a period of 7 years. EV is a rare genodermatosis characterized by a generalized infection with a specific group of human papilloma virus (HPV) and a propensity for developing skin malignant tumours in 30%-50% of patients. The diagnosis of EV was confirmed by histopathological and immunohistochemical findings. Three of our patients had the benign form of EV, which is characterized by monomorphous lesions and no malignant changes, whereas 10 had the malignant form, which is characterized by polymorphic lesions and development of cutaneous malignant tumours. All EV patients with the malignant form developed multiple skin tumours (77%). They started to appear at age 20, predominantly on the forehead (50%). Most were squamous cell carcinoma, extremely aggressive and invasive, which provoked metastasis and death in two patients.
Asunto(s)
Transformación Celular Neoplásica/patología , Epidermodisplasia Verruciforme/patología , Papillomaviridae/aislamiento & purificación , Lesiones Precancerosas/patología , Adolescente , Adulto , Distribución por Edad , Biopsia con Aguja , ADN Viral/análisis , Progresión de la Enfermedad , Epidermodisplasia Verruciforme/epidemiología , Epidermodisplasia Verruciforme/virología , Femenino , Estudios de Seguimiento , Humanos , Inmunohistoquímica , Incidencia , Masculino , Estudios Retrospectivos , Medición de Riesgo , Muestreo , Índice de Severidad de la Enfermedad , Distribución por Sexo , Factores de TiempoRESUMEN
Necrolytic migratory erythema is a rare skin condition that consists of migrating areas of erythema with blisters that heal with hyperpigmentation. It usually occurs in patients with an alpha islet cell tumor of the pancreas-or glucagonoma-and when associated with glucose intolerance, anemia, hyperglucagonemia, and weight loss defines the glucagonoma syndrome. We describe a 52-year-old female patient with necrolytic migratory erythema associated with glucagonoma syndrome who had metastatic disease at presentation and passed away one week after her admission. The autopsy showed a tumor in the body of the pancreas, which was diagnosed as a neuroendocrine tumor and confirmed by immunohistochemistry. The diagnosis of necrolytic migratory erythema is a matter of great importance, since it might be an auxiliary tool for the early detection of glucagonoma.
Asunto(s)
Eritema/etiología , Glucagonoma/complicaciones , Neoplasias Pancreáticas/complicaciones , Eritema/patología , Resultado Fatal , Femenino , Glucagonoma/patología , Humanos , Persona de Mediana Edad , Neoplasias Pancreáticas/patología , SíndromeRESUMEN
We describe a patient with multiple fibroepithelial basal-cell carcinoma (FEBCC) associated with seborrheic keratosis distributed in a neviform fashion on the left side of the body and clinically resembling skin tags.
Asunto(s)
Carcinoma Basocelular/patología , Queratosis Seborreica/patología , Nevo Pigmentado/patología , Neoplasias Cutáneas/patología , Abdomen , Adulto , Síndrome del Nevo Basocelular/patología , Carcinoma Basocelular/complicaciones , Diagnóstico Diferencial , Femenino , Humanos , Queratosis Seborreica/complicaciones , Pierna , Nevo Pigmentado/complicaciones , Neoplasias Cutáneas/complicacionesRESUMEN
OBJECTIVE: To study the articular inflammatory manifestations of leprosy. METHODS: Sixty patients with leprosy from a public clinic in São Paulo, Brazil, participated in a study regarding their articular manifestations. The diagnosis and classification of leprosy were established by the clinical picture, skin smears, skin biopsy, and delayed hypersensitivity test to Mycobacterium leprae antigens (Mitsuda test). According to the Madrid and Ridley-Jopling classifications, 46 patients had lepromatous leprosy, 7 had borderline leprosy, 4 had tuberculoid leprosy, and 3 had indeterminate leprosy. History, general and articular examinations, and roentgenograms were employed and complemented in several cases by scintigraphic examinations with technetium methylene diphosphonate and computed tomographic studies. RESULTS: Three patients were excluded from study due to an association with a rheumatic disease. Among the 57 remaining patients, 44 had peripheral arthritis characterized by involvement of small joints (23/44), large joints (4/44), or both (17/44). The mean duration of arthritis was 11 years (range 1 mo to 51 yrs). Arthritis was detected in all subtypes of patients with leprosy. Supplementary radiological evaluation established the extent of inflammation and diagnosis of sacroiliitis. The diagnosis of sacroiliitis, based on the presence of sclerosis, erosions, and narrowing of the cartilage space in the sacroiliac joints, was established in 35 of 55 radiographs. Sacroiliitis varied from grade I to III, according to the Bennet and Wood classification, and was bilateral in most cases (30/35). There was no significant correlation between low back pain and the finding of sacroiliitis. CONCLUSION: Articular inflammatory manifestations may exist in patients with different forms of leprosy, and can follow a chronic course. In addition, sacroiliitis is a common, previously unrecognized manifestation in patients with leprosy.
Asunto(s)
Artritis/etiología , Lepra/complicaciones , Adulto , Anciano , Artritis/diagnóstico por imagen , Artrografía , Huesos/diagnóstico por imagen , Enfermedad Crónica , Femenino , Cadera/diagnóstico por imagen , Humanos , Lepra/clasificación , Lepra/diagnóstico por imagen , Masculino , Persona de Mediana Edad , Mycobacterium leprae/inmunología , Cintigrafía , Articulación Sacroiliaca/diagnóstico por imagen , Esclerosis/etiologíaAsunto(s)
Quistes/etiología , Displasia Ectodérmica/complicaciones , Enfermedades del Cabello/etiología , Adulto , Quistes/tratamiento farmacológico , Displasia Ectodérmica/tratamiento farmacológico , Etretinato/uso terapéutico , Femenino , Enfermedades del Cabello/tratamiento farmacológico , Humanos , Queratolíticos/uso terapéuticoRESUMEN
One hundred and twenty-six patients with LE were studied. They were distributed as follows: 84 with DLE, 13 with SALE and 29 with SLE. Biopsies from the skin lesions were performed and submitted to DIF. Positive results were equal to 69, 61.5 and 72.4 percent of the DLE, SALE and SLE cases, respectively. These data are in accordance with the literature. IgM was the most frequently found immunoglobulin, followed by the association IgM + C3.